Physician profile
Michael Hunter Webb
NPI 1144855305
$1,407.15
in general payments reported to CMS, 2019-2025
9 companies · $1,275 in 2025
The $1,275 reported for 2025 was more than what 95% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $132 · 2025: $1,275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,407.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $382.13 | 2025 | Wavewriter Alpha Prime 16, Intracept Rf Probe |
| Spinal Simplicity, LLC | $269.74 | 2025 | Ha Minuteman G3-R |
| Biotronik Nro, INC. | $180.45 | 2025 | Prospera |
| Saluda Medical Americas, INC. | $174.40 | 2025 | Evoke |
| Nalu Medical, INC. | $143.29 | 2025 | Nalu Neurostimulation System |
| Tersera Therapeutics LLC | $124.99 | 2025 | Prialt |
| Averitas Pharma INC. | $97.93 | 2023 | Qutenza |
| Medline Industries LP | $18.55 | 2023 | |
| Collegium Pharmaceutical, INC. | $15.67 | 2023 | Xtampza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.